Skip to content

Telesis Bio Inc.

CIK 0001850079

← back to feed
Revenue (TTM)
$10.65M
+0.3% YoY Q3 Nov 2024
Net Income (TTM)
−$38.5M
+1.5% YoY Q3 Nov 2024
EPS Diluted (TTM)
−$23.96
+0.6% YoY Q3 Nov 2024
Gross Margin
39.3%
Q3 Nov 2024
Operating Margin
-327.3%
Q3 Nov 2024
Net Margin
-361.3%
Q3 Nov 2024
Free Cash Flow (TTM)
−$26.67M
Q3 Nov 2024
Cash
$3.72M
Q3 Nov 2024
Total Debt
$21.04M
Q3 Nov 2024
Shares Outstanding
1.78M sh
Q3 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings